Negative Hyperselection of Patients With RAS and BRAF Wild-Type Metastatic Colorectal Cancer Who Received Panitumumab-Based Maintenance Therapy

PURPOSE: We assessed the prognostic/predictive role of primary tumor sidedness and uncommon alterations of anti–epidermal growth factor receptor (EGFR) primary resistance (primary resistance in RAS and BRAF wild-type metastatic colorectal cancer patients treated with anti-EGFR monoclonal antibodies...

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:J Clin Oncol
Huvudupphovsmän: Morano, Federica, Corallo, Salvatore, Lonardi, Sara, Raimondi, Alessandra, Cremolini, Chiara, Rimassa, Lorenza, Murialdo, Roberto, Zaniboni, Alberto, Sartore-Bianchi, Andrea, Tomasello, Gianluca, Racca, Patrizia, Clavarezza, Matteo, Adamo, Vincenzo, Perrone, Federica, Gloghini, Annunziata, Tamborini, Elena, Busico, Adele, Martinetti, Antonia, Palermo, Federica, Loupakis, Fotios, Milione, Massimo, Fucà, Giovanni, Di Bartolomeo, Maria, de Braud, Filippo, Pietrantonio, Filippo
Materialtyp: Artigo
Språk:Inglês
Publicerad: American Society of Clinical Oncology 2019
Ämnen:
ORIGINAL REPORTS
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC6864846/
https://ncbi.nlm.nih.gov/pubmed/31539295
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.19.01254
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk